SCHEMBL7015776

SCHEMBL7015776

CCS(=O)(=O)NC(C(=O)NCc1ccc(OCc2ccccc2)c(OC)c1)C(C)C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.57
NPC1 O15118 2/20 0.57
PKM P14618 1/20 0.57
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
MTNR1A P48039 2/20 0.51
MTNR1B P49286 2/20 0.51
MAPK1 P28482 1/20 0.50
KDM4E B2RXH2 2/20 0.48
GAA P10253 2/20 0.48
CYP3A4 P08684 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
BCHE P06276 1/20 0.48
APP P05067 1/20 0.48
HPGD P15428 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
F2 P00734 1/20 0.47
F10 P00742 1/20 0.47
PRSS1 P07477 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7015773 1.00 RAB9A (0.57) RAB9ANPC1PKMMEN1KMT2A
SCHEMBL7605247 0.90 MTNR1A (0.56) RAB9ANPC1PKMMEN1KMT2A
SCHEMBL7103339 0.82 MEN1 (0.57) MEN1KMT2AMAPK1KDM4EGAA
SCHEMBL7103335 0.82 MEN1 (0.57) MEN1KMT2AMAPK1KDM4EGAA
SCHEMBL7103229 0.80 MEN1 (0.50) RAB9ANPC1PKMMEN1KMT2A
SCHEMBL7101839 0.79 MEN1 (0.49) MEN1KMT2AMAPK1GAASMN1; SMN2
SCHEMBL7095672 0.78 MEN1 (0.48) RAB9AMEN1KMT2AMAPK1HPGD
SCHEMBL7098173 0.78 KMT2A (0.48) MEN1KMT2AMAPK1GAASMN1; SMN2
SCHEMBL7104691 0.78 KMT2A (0.48) MEN1KMT2AMAPK1GAACYP3A4
SCHEMBL7095676 0.78 MEN1 (0.48) RAB9AMEN1KMT2AMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030224940-A1 Alpha-sulfin-and alpha-sulfonamino acid amide derivatives SYNGENTA CROP PROTECTION, INC. 2003-12-04 US disclosed
EP-1272461-A1 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDE DERIVATIVES Syngenta Participations AG (CH) 2003-01-08 EP disclosed
WO-2001079160-A1 ALPHA-SULFIN- AND ALPHA-SULFONAMINO ACID AMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2001-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030224940-A1 Alpha-sulfin-and alpha-sulfonamino acid amide derivatives STS, ARSA, SULT2A1 RAB9A 1826/4885NPC1 4401/4885PKM 3927/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.